Mumtaz Score for Readmission in Cirrhosis
ورودیهای بالینی بیمار
حداقل ۱۸ — حداکثر ۱۲۰ • واحد: years
حداقل ۱۰۰ — حداکثر ۱۶۰ • واحد: mEq/L
حداقل ۱ — حداکثر ۶ • واحد: g/dL
حداقل ۱ — حداکثر ۳۶۵ • واحد: days
حداقل ۰ — حداکثر ۲۰ • واحد: admissions
حداقل ۶ — حداکثر ۴۰ • واحد: points
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low Risk0–15
- Moderate Risk15–30
- High Risk30–50
- Very High Risk50–100
The Mumtaz Score for Readmission in Cirrhosis calculates predicting 30-day readmission risk in patients with cirrhosis following hospital discharge. Key inputs include age. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Predicts 30-day readmission risk in patients with cirrhosis following hospital discharge. This prognostic tool helps clinicians identify high-risk patients who may benefit from enhanced discharge planning, close outpatient follow-up, and preventive interventions to reduce readmission rates.
Clinical Indication
The Mumtaz Score for Readmission in Cirrhosis is indicated for bedside clinical practice to support Predicts 30-day readmission risk in patients with cirrhosis following hospital discharge. This prognostic tool helps clinicians identify high-risk patients who may benefit from enhanced discharge planning, close outpatient follow-up, and preventive interventions to reduce readmission rates.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: The model showed good discrimination (C-statistic 0.68-0.72) and calibration in validation studies.
Logistic regression model incorporating age, serum sodium, albumin, length of stay, previous admissions, MELD score, hepatic encephalopathy, and ascites with specific coefficients to calculate 30-day readmission probability
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| age | integer | Yes | Patient age in years(years) |
| serum_sodium | float | Yes | Serum sodium level. Hyponatremia is associated with increased readmission risk in cirrhosis patients(mEq/L) |
| albumin | float | Yes | Serum albumin level. Lower albumin indicates poor synthetic liver function and higher readmission risk(g/dL) |
| length_of_stay | integer | Yes | Length of current hospital stay in days. Longer stays may indicate more severe illness(days) |
| previous_admissions_6_months | integer | Yes | Number of hospital admissions in the previous 6 months. Prior admissions are strong predictors of readmission(admissions) |
| meld_score | integer | Yes | Model for End-Stage Liver Disease (MELD) score at discharge. Higher MELD scores indicate more severe liver disease(points) |
| hepatic_encephalopathy | string | Yes | Presence of hepatic encephalopathy during current admission. HE increases readmission risk |
| ascites | string | Yes | Presence of ascites during current admission. Ascites complications increase readmission risk |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–15 | Low Risk | Low 30-day readmission risk |
| 15–30 | Moderate Risk | Moderate 30-day readmission risk |
| 30–50 | High Risk | High 30-day readmission risk |
| 50–100 | Very High Risk | Very high 30-day readmission risk |
Evidence-Based References (EBM)
- Mumtaz K, Issak A, Porter K, Kelly S, Hanje J, Michaels AJ, et al. Validation of Risk Score in Predicting Early Readmissions in Decompensated Cirrhotic Patients: A Model Based on the Administrative Database. Hepatology. 2019;70(2):630-639. doi: 10.1002/hep.30274.DOI: 10.1002/hep.30274
- Berman K, Tandra S, Forssell K, Vuppalanchi R, Burton JR Jr, Nguyen JH, et al. Incidence and predictors of 30-day readmission among patients hospitalized for advanced liver disease. Clin Gastroenterol Hepatol. 2011;9(3):254-9. doi: 10.1016/j.cgh.2010.10.035.DOI: 10.1016/j.cgh.2010.10.035
- Volk ML, Tocco RS, Bazick J, Rakoski MO, Lok AS. Hospital readmissions among patients with decompensated cirrhosis. Am J Gastroenterol. 2012;107(2):247-52. doi: 10.1038/ajg.2011.314.DOI: 10.1038/ajg.2011.314